xMAP
The firm said that its Verigene II multiplex system is on track to launch in mid-2020 among a number of new products scheduled for release this year.
Luminex Q4 Revenues Rise 12 Percent
The firm submitted its Verigene II Gastrointestinal Flex Assay to the FDA in Q4 and expects to submit Verigene II Respiratory Flex Assay to the agency in Q1 2020.
Protagen, Qiagen Collaborate to Advance Development of Protein-based CDx for Autoimmune Diseases
Protagen announced a long-term collaboration agreement with Qiagen to provide pharmaceutical partners access to technology that would advance the development of protein-based companion tests for autoimmune disorders.
Luminex Q3 Revenues Jump 12 Percent on Assay Sales
NEW YORK (GenomeWeb) — Luminex reported after the close of the market Monday a 12 percent spike in third quarter revenues driven primarily by growth in assay sales across all major product categories.
Federal Court Dismisses IP Infringement Claims Against Luminex
NEW YORK (GenomeWeb News) – A federal court has dismissed claims against Luminex that had alleged patent infringement.
Nov 4, 2013
Irori Sues Luminex for Patent Infringement
Mar 20, 2013
Dec 13, 2012
Jul 12, 2012
Aug 23, 2011
Aug 17, 2011